October 7, 2024 HNC Comments on 2025 Medicare Program Home Health Prospective Payment System Rate Update and Other Medicare Policies
October 7, 2024 HNC Comments to Arkansas Department of Human Services on Proposed Rate Change for Specialized Formula and Associated Supplies
May 28, 2024 HNC Comments to CMS on Inpatient Rehabilitation Facility Prospective Payment System for FY 2025
December 1, 2023 HNC Comments to HHS, DOL, and DOT on Coverage of Over-the-Counter Preventive Services
June 5, 2023 HNC Comments to CMS Inpatient Acute Care Hospitals and the Long-Term Care Hospital for FY 2024
June 2, 2023 HNC Comments to CMS Inpatient Rehabilitation Facility Prospective Payment System for FY 2024
April 8, 2022 Healthcare Nutrition Council Comments on Docket Number FDA-2022-N-0116 Rare Disease Day Public Meeting
March 4, 2022 Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies
December 30, 2020 HNC and ASPEN Comments on Docket Number CMS-2020-0128 titled “Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Policy Issues and Level II of the Healthcare Common Procedure Coding System (HCPCS) (CMS-1738-P)”
October 5, 2020 Medicare Program; CY 2021 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies, Proposed Rule
June 18, 2020 HNC Comments to CMS to Cancel and Rebid or Delay the Round 2021 Competitive Bidding Program for Enteral Nutrition due to COVID-19
June 1, 2020 Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency
October 23, 2019 Re: DMEPOS Competitive Bidding Program – Review of Bona Fide Bids and Meeting Request
September 27, 2019 HNC Comments on the 2020 Physician Fee Schedule and Quality Payment Program Proposed Rule
June 10, 2019 Re: DMEPOS Competitive Bidding Program –Delay of Opening of 2021 Bid Window and Bona Fide Bid Guidance
December 3, 2018 HNC Comments to FDA Collection of Information re Investigational New Drug Applications Docket No. FDA-2014-N-1721
October 11, 2018 Joint INCA-HNC Comments to FDA on Nutrition Innovation Strategy Docket No. FDA-2018-N-2381-0317
June 22, 2018 HNC Comments to CMS Medicare Hospital Inpatient Prospective Payment System Docket No. CMS-1694-P
March 30, 2018 HNC Comments to USDA on Dietary Guidelines for Americans Topics and Questions Docket No. FNS-2018-0005
February 5, 2018 HNC Comments to FDA Center for Drug Evaluation and Research (CDER) Docket No. FDA-2017-N-5101
February 5, 2018 HNC Comments to FDA Center for Food Safety and Applied Nutrition (CFSAN) Docket No. FDA-2017-N-5094
December 11, 2016 Quality Measure Development to satisfy the Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) domain of: Transfer of Health Information and Care Preferences When an Individual Transitions
October 7, 2016 Quality Measure Development and Maintenance for CMS Programs Serving Medicare-Medicaid Enrollees and Medicaid-Only Enrollees. Measures for Medicaid enrollees in managed long-term services and supports (MLTSS)
October 7, 2016 Quality Measure Development and Maintenance for CMS Programs Serving Medicare-Medicaid Enrollees and Medicaid-Only Enrollees. Measures for dual enrollees and Medicaid beneficiaries using home- and community-based services (HCBS)
October 7, 2016 Quality Measure Development and Maintenance for CMS Programs Serving Medicare-Medicaid Enrollees and Medicaid-Only Enrollees. Measures for Medicaid beneficiaries with complex costs and high needs (BCN), substance use disorders (SUD), and physical and mental health integration needs (PMH)
